|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||98.97 - 100.71|
|52 Week Range||98.97 - 100.71|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 23, 2018 - Jul 27, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Moody's Investors Service, ("Moody's") has upgraded the rating on one class and affirmed the rating on one class in J.P. Morgan Chase Commercial Mortgage Securities Corp. 2004-C3, Commercial ...
Quest Diagnostics' (DGX) year-over-year revenue improvement in Q1 came on the back of successful execution of its two-point strategy of accelerating growth and driving operational excellence.
Quest Diagnostics Incorporated (NYSE:DGX) is currently trading at a trailing P/E of 18x, which is lower than the industry average of 21.4x. While DGX might seem like an attractive stockRead More...
The Secaucus, New Jersey-based company said it had net income of $1.27 per share. Earnings, adjusted for one-time gains and costs, were $1.52 per share. The results matched Wall Street expectations. The ...
- Revenues of $1.88 billion , up 3.7% from 2017 - Reported diluted EPS of $1.27 , up 9.5% from 2017 - Adjusted diluted EPS excluding amortization of $1.52 , up 24.6% from 2017 - Outlook for full year 2018 ...
NEW YORK, NY / ACCESSWIRE / April 19, 2018 / Quest Diagnostics Incorporated (NYSE: DGX ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 19, 2018 at 8:30 AM Eastern ...
The economic and earnings calendars on Thursday should be fairly quiet, as investors continue to focus on the Treasury yield curve, which some fear is signaling recession.
On a positive note, the broader healthcare looks delighted with the massive tax cuts. Also, the scenario within the Medical Device space seems equally bright.
Quest Diagnostics (DGX) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
On April 12, 2018, UnitedHealth Group (UNH) closed at $224.75. The stock reached a 52-week high on January 29, 2018, and a 52-week low on April 12, 2017. Since then, the stock has risen significantly, by ~36%. UNH is currently trading higher than its 50-day and 200-day moving averages of $224.46 and $219.34, respectively.
Quest Diagnostics' (DGX) successful strategies to build esoteric testing business and boost profit margins raise optimism among investors on the stock.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting DGX. Over the last one-month, outflows of investor capital in ETFs holding DGX totaled $15.80 billion.
It's a giant leap for blockchain in healthcare, but not even a tiny step for the stocks of the companies involved.
SECAUCUS, N.J., April 9, 2018 /PRNewswire/ -- Despite record high rates of new cases of sexually transmitted diseases (STDs), young women who are sexually active often don't talk to their clinicians about sex and STD risk, and many aren't being tested for infection or disease as guidelines recommend, according to new research from Quest Diagnostics (DGX), the world's leading provider of diagnostic information services.
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 800-846-1910 for domestic callers or 402-280-9953 for international callers. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on April 19, 2018 until midnight Eastern Time on May 3, 2018. Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
The blockchain partnership follows a separate effort announced in January by Amazon, Warren Buffett's Berkshire Hathaway and JPMorgan Chase to reduce health costs.
Humana is joining some of the largest health care companies in the nation for this venture.
Five leading health care organizations – Humana , MultiPlan, Quest Diagnostics and UnitedHealth Group’s Optum and UnitedHealthcare – today announced that they are launching a pilot program applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health care provider demographic data, a critical, complex and difficult issue facing organizations ...
LONDON, UK / ACCESSWIRE / April 02, 2018 / Active-Investors has a free review on Quest Diagnostics Inc. (NYSE: DGX ) following the Company's announcement that it will begin trading ex-dividend on April ...
UnitedHealth Group and Humana are launching a pilot program to study whether blockchain technology can help track provider information.
If you are interested in cashing in on Quest Diagnostics Incorporated’s (NYSE:DGX) upcoming dividend of $0.5 per share, you only have 3 days left to buy the shares before itsRead More...